ACCESS TO INNOVATION AND ECONOMIC BURDEN-A CASE OF NON-SMALL CELL LUNG CANCER IN A PATIENT ACCESS PROGRAM IN QINGDAO, CHINA

被引：0
|
作者：
Chen, W. [1 ]
Lin, Y. [1 ]
Zhang, L. [1 ]
机构：
[1] Fudan Univ, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1368
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN351
引用
收藏
页码：A492 / A492
页数：1
相关论文
共 50 条
  • [31] Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement
    Jeon, Youngkyung
    Jung, Hyun Ae
    Park, Sehhoon
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Lee, Se-Hoon
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1144 - 1151
  • [32] Retrospective analysis of patients with advanced non-small cell lung cancer who participated in the extended access program (EAP) of gefitinib
    Kang, J. -H.
    Kang, S. Y.
    Kim, H. T.
    Lee, J. S.
    Shim, B. Y.
    Park, B. -B.
    Park, J. O.
    Park, K.
    Shin, S. W.
    Heo, D. S.
    Kim, D. -W.
    Ryoo, B. -Y.
    Lee, J. C.
    Na, I. I.
    Kim, S. -W.
    Suh, C.
    Cho, B. C.
    LUNG CANCER, 2006, 52 : S23 - S24
  • [33] An expanded access program of osimertinib (Tagrisso) in patients with advanced non-small cell lung cancer: data report from Germany
    Stratmann, J. A.
    Hornetz, S.
    Griesinger, F.
    Wolf, J.
    Christoph, D. C.
    Sackmann, S.
    Spengler, W.
    Bischoff, H.
    Schaefer, M.
    Alt, J.
    Mlueller, A.
    Laack, E.
    Kimmich, M.
    Sebastian, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 170 - 170
  • [34] A case of primary non-small cell lung cancer with synchronous small cell lung cancer
    Wang, Hanli
    Lu, Zhiwei
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 171 - 174
  • [35] Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series
    Ahmed, Tahreem
    Vial, Macarena R.
    Ost, David
    Stewart, John
    Hasan, Muhammad A.
    Grosu, Horiana B.
    LUNG CANCER, 2018, 122 : 220 - 223
  • [36] Real-World Results in Non-Squamous Non-Small Cell Lung Cancer Patients: Italian Nivolumab Expanded Access Program
    Grossi, F.
    Crino, L.
    Delmonte, A.
    Turci, D.
    Signorelli, D.
    De Marinis, F.
    Parra, H. Soto
    Galetta, D.
    Cappuzzo, F.
    Sperandi, F.
    Tiseo, M.
    Puppo, G.
    Roila, F.
    Migliorino, M. R.
    Tonini, G.
    Cognetti, F.
    Santoro, A.
    Tassinari, D.
    Scoppola, A.
    Giannarelli, D.
    Cortesi, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1841 - S1841
  • [37] TIMELY REIMBURSEMENT: THE IMPACT OF EARLY ACCESS PROGRAMMES IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Webb, S.
    Mercure, J.
    VALUE IN HEALTH, 2023, 26 (12) : S263 - S263
  • [38] Economic value of gemcitabine in non-small cell lung cancer
    CopleyMerriman, C
    Martin, C
    Johnson, N
    Sacristan, JA
    Drings, PA
    Bosanquet, N
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 90 - 98
  • [39] Improvements in access to cancer clinical trials facilitated by comprehensive genomic profiling in non-small cell lung cancer
    Lee, Woojung
    Spencer, Scott
    Carlson, Josh John
    Dinh, Tam
    Dayer, Victoria
    Cummingham, Rachel
    Kaa, Kathleen
    Martucci, Gary
    Hynes, Maggie
    Veenstra, David Leroy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [40] EVALUATE THE ECONOMIC BURDEN OF NON SMALL CELL LUNG CANCER IN VIETNAM
    Nguyen, T. T. T.
    Dinh, H. T.
    VALUE IN HEALTH, 2014, 17 (03) : A79 - A79
12345